Show simple item record

dc.contributor.advisorAfrose, Dr. Afrina
dc.contributor.authorSultana, Sadia
dc.date.accessioned2023-05-16T06:24:23Z
dc.date.available2023-05-16T06:24:23Z
dc.date.copyright2022
dc.date.issued2022-01
dc.identifier.otherID: 18146093
dc.identifier.urihttp://hdl.handle.net/10361/18299
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.en_US
dc.descriptionCataloged from PDF version of thesis.
dc.descriptionIncludes bibliographical references (pages 46-55).
dc.description.abstractCoronavirus disease 2019 also known as COVID-19, is an acute respiratory condition (Severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2) caused by a novel coronavirus that was discovered for the first time in Wuhan, China’s Hubei Province, during a respiratory illness outbreak. The World Health Organization declared the COVID-19 pandemic a worldwide health emergency. The aim of this article is to evaluate the drugs that are currently used for the COVID 19 treatment and to outline the mechanism of actions and therapeutic efficacy of these drugs along with the comparison between them. This review has been conducted with a comprehensive literature analysis of clinical characteristics and therapies of the novel COVID 19 using internet databases with the recent relevant publications and research. Remdesivir, dexamethasone and amantadine are more effective than other drugs for people who are hospitalized with COVID-19 and need supplemental oxygen or have a higher risk of serious illness.en_US
dc.description.statementofresponsibilitySadia Sultana
dc.format.extent55 pages
dc.language.isoenen_US
dc.publisherBrac Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectRemdesiviren_US
dc.subjectHydroxychloroquine and chloroquineen_US
dc.subjectAzithromycinen_US
dc.subjectDexamethasoneen_US
dc.subjectCOVID 19en_US
dc.subject.lcshCOVID-19 (Disease) -- Treatment
dc.titleMedications used for covid-19 treatment and a comparison of their mechanism of action and therapeutic efficacyen_US
dc.typeThesisen_US
dc.contributor.departmentDepartment of Pharmacy, Brac University
dc.description.degreeB. Pharmacy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record